Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Vagus Nerve Stimulation Market: By Product Type, By Application, By End User, and Others), and Geography
Vagus Nerve Stimulation Market: By Product Type, By Application, By End User, and Others), and Geography
Vagus Nerve Stimulation Market size was valued at US$ 562.8 million in 2022 and is expected to reach US$ 1,198.2 million by 2028, at a significant CAGR of 11.4% from 2023-2029. Vagus nerve stimulation process involves implantation of a device that stimulates the vagus nerve with electrical impulse. The vagus nerves are a pair of nerves that start in the brain and run through the body. These nerves play a major role in receiving messages between the brain and the body.
The vagus nerve stimulation is most often used to treat epilepsy when other treatments havent worked. The devices are designed to prevent seizures by sending regular, mild pulses of electrical energy to the brain via the vagus nerve. Vagus nerve stimulation device is sometimes referred to as a cardiac pacemaker for the brain. The device is placed under the skin on the chest wall and a wire runs from it to the vagus nerve in the neck. The vagus nerve travels through neck and passes between the chest and abdomen and the lower part of the brain. Vagus nerve stimulation (VNS) is a medical treatment that involves delivering electrical impulses to the vagus nerve in order to manage and treat various illnesses such as depression and epilepsy. The stimulator is implanted under the skin on the chest, where the wire connects it to the left vagal nerve, in this procedure.
Study Period
2024-2030Base Year
2023CAGR
11.4%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Ascend in commonness of neurological and cardiovascular issue, increment in geriatric populace, development in help from government and private associations, and presentation of positive repayment arrangements drive the market. In any case, surprising expense of these gadgets and complexities related with vagus nerve stimulation devices market limit the market development. Moreover, high selection rate of negligibly obtrusive VNS methodology and improvement of cutting edge treatments for neurological scatters drive the market development amid the gauge time frame. Nonetheless, mind-boggling expense of gadgets, high support and entanglement identified with vagus nerve stimulation, and stringent administrative endorsements for these gadgets are limiting the development of the global VNS Market.
Geographically vagus nerve stimulation (VNS) market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America rules the global vagus nerve stimulation devices because of expanding inclination by medicinal services authorities of the locale for vagus nerve stimulation devices market. Also, the nearness of good repayment arrangements, accessibility of created human services foundation, and expanded patient mindfulness are factors boosting the market development for vagus nerve stimulation devices market.
North America is trailed by Europe. Asia Pacific is a developing business sector for vagus nerve stimulation devices market. China and India are relied upon to be the quickest developing markets because of increment in social insurance use, ascend in government activity and use increment in quiet pool, and development in persistent mindfulness. Be that as it may, in areas, for example, Middle East and Africa, factors, for example, mind-boggling expense of treatment, absence of accessibility of created human services foundation, and poor patient instruction are controlling the development of the vagus nerve stimulation market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2022 |
US$ 562.8 million |
|
Market Size in 2028 |
US$ 1,198.2 million |
|
Market CAGR |
11.4% |
|
By Type |
|
|
By Indication |
|
|
By End User |
|
Download Free Sample Report
The global vagus nerve stimulation market size was valued at US$ 562.8 million in 2022 and is projected to grow at a CAGR of 11.4% from 2024-2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1.Executive Summary |
| 2.Global Vagus Nerve Stimulation (VNS) Market Introduction |
| 2.1.Global Vagus Nerve Stimulation (VNS) Market - Taxonomy |
| 2.2.Global Vagus Nerve Stimulation (VNS) Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.End user |
| 2.2.4.Region |
| 3.Global Vagus Nerve Stimulation (VNS) Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Vagus Nerve Stimulation (VNS) Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Vagus Nerve Stimulation (VNS) Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Implantable VNS |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. External VNS |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Vagus Nerve Stimulation (VNS) Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Depression |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Epilepsy |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Migraine |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Vagus Nerve Stimulation (VNS) Market By End user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ambulatory Surgical Centers (ASCs) |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Vagus Nerve Stimulation (VNS) Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Vagus Nerve Stimulation (VNS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Implantable VNS |
| 9.1.2.External VNS |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Depression |
| 9.2.2.Epilepsy |
| 9.2.3.Migraine |
| 9.3. End user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Ambulatory Surgical Centers (ASCs) |
| 9.3.3.Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Vagus Nerve Stimulation (VNS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Implantable VNS |
| 10.1.2.External VNS |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Depression |
| 10.2.2.Epilepsy |
| 10.2.3.Migraine |
| 10.3. End user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Ambulatory Surgical Centers (ASCs) |
| 10.3.3.Others |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Vagus Nerve Stimulation (VNS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Implantable VNS |
| 11.1.2.External VNS |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Depression |
| 11.2.2.Epilepsy |
| 11.2.3.Migraine |
| 11.3. End user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Ambulatory Surgical Centers (ASCs) |
| 11.3.3.Others |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Vagus Nerve Stimulation (VNS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Implantable VNS |
| 12.1.2.External VNS |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Depression |
| 12.2.2.Epilepsy |
| 12.2.3.Migraine |
| 12.3. End user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Ambulatory Surgical Centers (ASCs) |
| 12.3.3.Others |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Vagus Nerve Stimulation (VNS) Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Implantable VNS |
| 13.1.2.External VNS |
| 13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Depression |
| 13.2.2.Epilepsy |
| 13.2.3.Migraine |
| 13.3. End user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Ambulatory Surgical Centers (ASCs) |
| 13.3.3.Others |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.LivaNova PLC (UK) |
| 14.2.2.EnteroMedics Inc. (US) |
| 14.2.3.ElectroCore Medical LLC (US) |
| 14.2.4.Boston Scientific Corporation (US) |
| 14.2.5.Cyberonics, Inc. (US) |
| 14.2.6.NeuroMetrix, Inc.(US) |
| 14.2.7.ImThera Medical (US) |
| 14.2.8.Inspire Medical Systems, Inc.(US) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.